Dioscin induced activation of p38 MAPK and JNK via mitochondrial pathway in HL-60 cell line

Ying Wang1, Qing-Yu He2, Jen-Fu Chiu3

  • 1State Key Laboratory of Quality Research in Chinese Medicine and Institute of Chinese Medical Sciences, University of Macau, Macao SAR, China.

Insights

Dioscin, a saponin, effectively inhibits leukemia cell growth by triggering apoptosis. This occurs through the activation of specific signaling pathways, suggesting its potential as a novel cancer therapy drug lead.

Area of Science:

  • Pharmacology
  • Molecular Biology
  • Cancer Research

Background:

  • Saponins show potential in cancer therapy, but their detailed mechanisms are unclear.
  • Understanding signaling pathways is crucial for developing novel anticancer agents.

Purpose of the Study:

  • To investigate the anticancer mechanisms of dioscin in human myeloblast leukemia HL-60 cells.
  • To elucidate the specific signaling pathways involved in dioscin's cytotoxic effects.

Main Methods:

  • Cell viability assays to assess growth inhibition.
  • Apoptosis assays including phosphatidylserine externalization and caspase activation.
  • Western blotting to detect protein phosphorylation (p38 MAPK, JNK) and cleavage (PARP-1, lamin A/C).
  • Mitochondrial function analysis using inhibitors and antioxidants.

Main Results:

  • Dioscin suppressed HL-60 cell growth dose-dependently.
  • Dioscin induced apoptosis via caspase activation (3, 7, 8, 9, 10) and mitochondrial pathway.
  • Mitochondrial reactive oxygen species and membrane potential loss mediated p38 MAPK and JNK phosphorylation.

Conclusions:

  • Dioscin induces apoptosis in leukemia cells through p38 MAPK and JNK activation via the mitochondrial pathway.
  • Dioscin's mechanism involves caspase-dependent signaling initiated by mitochondrial dysfunction.
  • Dioscin shows promise as a potential therapeutic agent for myeloblast leukemia.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.3K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.2K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
4.7K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.2K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
Signal Transduction: Overview01:26

Signal Transduction: Overview

Cells respond to many types of information, often through receptor proteins positioned on the membrane. They respond to chemical signals, such as hormones, neurotransmitters, and other signaling molecules, initiating a series of molecular reactions to produce an appropriate response. This is called signal transduction. Cells also coordinate different responses elicited by the same signaling molecule via mediators, allowing molecular cross-talk.
Typically, signal transduction involves three...
8.6K